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OBJECTIVES We sought to compare symptoms of depression and anxiety as predictors of incomplete
recovery after a first myocardial infarction (MI).
BACKGROUND Depressive symptoms have been related to post-MI mortality and health care consumption,
but little is known about the effect of anxiety. We wanted to examine the effect of emotional
distress on health care consumption and whether depressive symptomatology is a better
predictor of prognosis than anxiety.
METHODS Subjects were 318 men (mean age 58 years) who completed the depression, anxiety, and
hostility scales from the 90-item symptom check list after they survived a first MI.
RESULTS After an average follow-up of 3.4 years, there were 25 cardiac events (fatal or non-fatal MI).
Symptoms of both depression (hazard ratio [HR] 2.32, 95% confidence interval [CI] 1.04 to
5.18; p 0.039) and anxiety (HR 3.01, 95% CI 1.20 to 7.60; p 0.019) were associated with
cardiac events, adjusting for age, left ventricular ejection fraction, and use of antidepressants.
However, a multivariate analysis including all three negative emotions indicated that
symptoms of anxiety (HR 2.79, 95% CI 1.11 to 7.03; p  0.029) explained away the
relationship between depressive symptoms and cardiac events. Regarding health care
consumption, anxiety (OR 2.00, 95% CI 1.24 to 3.22; p  0.005), but not depression/
hostility, was a predictor of cardiac rehospitalization and frequent visits at the cardiac
outpatient clinic.
CONCLUSIONS Symptoms of depression and anxiety were associated with cardiac events. Anxiety was an
independent predictor of both cardiac events and increased health care consumption and
accounted for the relationship between depressive symptoms and prognosis. Symptoms of
anxiety need to be considered in the risk stratification and treatment of post-MI
patients. (J Am Coll Cardiol 2003;42:1801–7) © 2003 by the American College of
Cardiology Foundation
Negative emotions, such as depression and anxiety, have
been related to coronary artery disease (CAD) (1–3) and a
poor prognosis after myocardial infarction (MI) (4). Possi-
ble mechanisms linking negative emotions to the post-MI
period include increased vulnerability to arrhythmias as a
result of increased sympathic tone (5) and increased platelet
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aggregation (6). It is unclear whether treatment of depres-
sion may lead to a decrease in post-MI mortality (7), but the
findings of a recent study suggest that reducing emotional
stress may improve the prognosis (8).
Depression is frequently studied and considered as a
pathogenic factor in post-MI patients (9–12). Minor de-
pression and depressive symptoms also have a negative effect
on prognosis in cardiac patients (13). The increased risk of
cardiac events may extend to patients with symptoms of
negative affect other than depression (14,15). In healthy
populations, anxiety (1–3) and anger (16) have been asso-
ciated with the incidence of cardiac events, but less is known
about the role of anxiety and anger in post-MI patients.
Some studies have found that symptoms of depression and
anxiety (17,18) or anxiety alone (19) did not predict mor-
tality in MI patients but did predict quality of life among
those MI patients who lived to 12 months. Other studies
reported that both depression and anxiety, independent of
each other, predicted cardiac events (20) or CAD (21).
However, there has been a tendency to focus on only one
negative emotion at a time (15). Hence, the question remains
whether symptoms of depression play a specific role in the
prognosis of post-MI patients or whether symptoms of other
negative emotions such as anxiety and anger have a comparable
adverse effect on recovery after MI. In psychiatric patients,
anxiety and depression frequently co-occur, and co-morbid
anxiety has been associated with a greater severity of depressive
disorder and a poor response to anti-depressive treatment
(22–27). In depressed post-MI patients, evidence suggests that
co-morbid anxiety rather than pure depression may account for
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reduced heart rate variability as a cardiotoxic factor (28). Of
note, pharmacologic treatment of anxiety may also decrease the
risk of major depression (27).
Most studies investigating the relationship between psy-
chological factors and prognosis after MI focus on mortality
and new cardiac events (29–31). Negative emotions may
also have an adverse effect on other “softer” end points such
as angina, quality of life, and incomplete recovery (32). The
effect of depression on angina and re-hospitalization is even
more strongly established than its effect on mortality (33).
This is reason for concern because adverse outcomes also
represent increased health care costs (34).
The purpose of the present study was twofold. First, we
wanted to examine whether depression is a better predictor
of incomplete recovery after MI than anxiety. Second, we
wanted to examine the effect of emotional distress not only
on major cardiac events but also on re-hospitalization and
increased health care consumption.
METHODS
Patients. Between May 1994 and September 1999, a total
of 407 eligible male patients were admitted to the First
Heart Aid of the Academic Hospital of Maastricht (AZM)
with acute MI. Inclusion criteria of the present study were
male gender, first MI, clinical picture and electrocardio-
graphic signs typical of acute MI, and a maximum value of
the enzyme aspartate aminotransferase (ASAT) of at least
80 U/l (twice above the upper limit) (35). Patients were
excluded who had a major psychiatric disorder other than
affective disorders (e.g., schizophrenia, dementia, present
psychotic episode). Additionally, patients who were unable
to communicate reliably (e.g., because of cognitive dysfunc-
tion or not speaking Dutch) or with a co-morbid life-
threatening disease were excluded. The local ethics com-
mittee approved this study.
Of the 407 eligible patients, 89 (21.9%) refused to
participate and 318 (78.1%) gave written, informed consent
before inclusion. A refusal rate of 21.9% is comparable to
other studies in which MI patients were screened for
depression (12,29). Of the 318 patients, 14 were treated in
a randomized, placebo-controlled trial of fluoxetine during
25 weeks (36). After the trial, they were offered further
treatment at the mood disorder clinic of AZM if necessary.
Furthermore, another 11 patients were treated with antide-
pressants by the general practitioner or at the mood disorder
clinic of AZM.
Assessment of emotional distress. The 90-item Symptom
Check List (SCL-90), which is a well-validated and widely
used self-assessment scale (37,38), was used to measure
emotional distress. Each of the items of the SCL-90 ranges
from 0 to 4, with 0 indicating no complaint and 4 maximal
complaint. Patients filled out the SCL-90 one month after
MI at home or during the first post-MI visit at the
outpatient clinic of the Department of Cardiology. The
scales of “depression” (16 items), “anxiety” (10 items), and
“hostility” (6 items) from the SCL-90 were scored for the
purpose of the present study. These scales were conceptu-
alized as markers of emotional distress. In previous research,
we evaluated the SCL-90 depression scale in patients with
post-MI depression and found it to be a valid instrument,
with a sensitivity of 81.1% and a specificity of 83.5%. In
comparison, the Beck Depression Inventory had a sensitiv-
ity of 83.8% and a specificity of 71.7% (39).
End points. The end points in this study were major
cardiac events and health care consumption during an
average follow-up period of 3.4 years (range 1 to 70
months). Major cardiac events were defined as cardiac death
or recurrent MI, as diagnosed by the attending cardiologist.
Increased health care consumption was defined as cardiac
rehospitalization and/or frequent visits (6 visits during
follow-up) at the cardiac outpatient clinic. Patients without
cardiac events during the follow-up period and with an
average number of visits at the cardiac outpatient clinic were
considered to be “event free.”
Cardiac variables. Left ventricular ejection fraction
(LVEF) was recorded one month after MI as a measure of
disease severity. Data on intervention at the time of MI
(thrombolysis, percutaneous transluminal coronary angio-
plasty, coronary artery bypass graft surgery), medication
(beta-blockers, platelet aggregation inhibitors, angiotensin-
converting enzyme inhibitors), and cardiovascular risk fac-
tors (smoking, hypertension, hypercholesterolemia, diabe-
tes) were taken from the patients’ records.
Analyses. All data were entered into a computerized data
base and analyzed using SPSS version 6.0 (SPSS Inc.,
Chicago, Illinois) standard software. According to the
results of follow-up, patients were classified into one of
three groups: patients with a major cardiac event; patients
with increased health care consumption; and event-free
patients. To determine the prognostic power of emotional
distress, scores on the depression, hostility, and anxiety
subscales were dichotomized according to the cut-off values
for high-risk psychopathology (38): 23 for depression; 12
for anxiety; and 7 for hostility. The LVEF was dichoto-
mized at 50%, using standards of a former publication on
CAD patients (8). A median split was used to dichotomize
patients according to age (median 58 years) and the number
of visits at the outpatient cardiology clinic (median 6 visits).
Differences in baseline characteristics between the three
Abbreviations and Acronyms
ASAT  aspartate aminotransferase
AZM  Academic Hospital Maastricht
CAD  coronary artery disease
CHD  coronary heart disease
CI  confidence interval
HR  hazard ratio
LVEF  left ventricular ejection fraction
MI  myocardial infarction
OR  odds ratio
SCL-90  90-item Symptom Check List
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groups were tested by the independent t test for continuous
variables and the chi-square test for all dichotomous vari-
ables. Fisher exact probabilities were calculated when they
were expected.
Multivariate Cox regression analysis was used to examine
the SCL-90 depression, anxiety, and hostility subscales
separately as predictors of major cardiac events. To select
appropriate co-variates for statistical control, all baseline
variables were dichotomized (at predetermined points).
Those variables significantly related to major cardiac events
in the univariate Cox regression models were entered into
the multiple Cox regression analysis, followed by the addi-
tion of the SCL-90 depression, anxiety, and hostility
subscales. Because anti-depressive agents can flaw the im-
pact of depression on cardiac prognosis, we also included the
use of antidepressants as a co-variate in our model. Finally,
a stepwise multivariate Cox regression analysis, including all
three negative emotions (SCL-90 subscales of depression,
anxiety, and hostility), was used to examine these emotions
as independent predictors of major cardiac events.
Regarding analysis of SCL-90 depression, anxiety, and
hostility subscales as predictors of health care consumption,
univariate logistic regressions were first performed. Those
baseline variables significantly related to health consump-
tion were entered in a multivariate logistic regression model,
followed by the addition of the SCL-90 subscales. Finally,
multivariate logistic regression with all three negative emo-
tions was used. A two-tailed p value 0.05 was considered
to be significant.
RESULTS
Patients. The average (SD) age of the 318 included men
was 58  11 years, and the mean LVEF and maximum
ASAT scores were 51  9.8% and 247  182 U/l,
respectively. There were no differences between the partic-
ipating and non-participating groups with respect to age,
maximum ASAT, or LVEF. Of the 318 participants, 91.9%
were prescribed platelet aggregation inhibitors, 58.2% beta-
blockers, 45.2% lipid-lowering drugs, 36.2% angiotensin-
converting enzyme inhibitors, 9% diuretics, and 5.7% oral
antidiabetic agents. Fifty-four percent of patients were
smoking before MI, 20.4% were known to have hypercho-
lesterolemia, 8.5% had diabetes, and 28% had hypertension.
Next, we evaluated whether not only age and LVEF but also
medication and risk factors for CAD were associated with
the distress variables of depression, anxiety, and hostility
(Table 1). Age under 58 years was associated with patients
with depressive symptoms (p  0.031), as was smoking (p
 0.003). Diabetes, prescription of oral antidiabetic agents,
and platelet aggregation inhibitors were associated with
symptoms of anxiety (p  0.043, 0.047, and 0.026, respec-
tively). Hyperlipidemia was associated with symptoms of
hostility (p  0.022), as was smoking (p  0.026). Accord-
ing to the psychological assessment one month after MI,
47.1% of the patients scored above the cut-off value of the
SCL-90 depression subscale, 59.5% above the anxiety sub-
scale, and 62.1% above the hostility subscale.
Cardiac events. One hundred forty-four patients (45.2%)
were event-free during follow-up, whereas 25 (7.9%) had
experienced a major cardiac event. On univariate Cox
regression analyses (Table 2), LVEF 50% was signifi-
cantly associated with cardiac death or recurrent MI (p 
0.031). There was also a trend for age 58 years (p 
0.066). The other cardiovascular variables (i.e., beta-
blockers, invasive intervention, smoking, hypercholesterol-
emia, hypertension, and diabetes) were not associated with
cardiac events (Table 2) or health care consumption (Table 3).
Symptoms of anxiety, but not depression, were associated
with cardiac events on univariate analysis (Fig. 1). After
adjusting for age, LVEF, and the use of antidepressants,
symptoms of both depression and anxiety were associated
with cardiac events (p  0.039 and 0.019, respectively)
(Table 4). There was no relation with hostility.
Increased health care consumption. Of the 318 male
patients with a first MI, 149 (46.9%) had increased health
care consumption (i.e., frequent visits to the outpatient
cardiac clinic or rehospitalizations due to cardiac events) up
to six years after MI. On univariate analyses (Table 3), there
were no cardiovascular variables related to increased health
care consumption, although there was a trend for LVEF
50% to be related to increased health care consumption
(p  0.069).
Regarding emotional distress as a determinant, depressive
and anxious symptoms at baseline were associated with
increased health care consumption during follow-up (p 
0.047 and 0.004, respectively) (Table 3). After adjusting for
age, LVEF, and the use of antidepressants, anxiety was the
only negative emotion that was significantly associated with
the secondary end point (odds ratio [OR] 2.00, 95%
confidence interval [CI] 1.23 to 3.26; p  0.006) (i.e.,
frequent cardiac outpatient visits and rehospitalizations due
to cardiac events) (Table 4). Hostility was not related to
increased health care consumption.
Independent predictors of end points. A multivariate
analysis including all three negative emotions indicated that
symptoms of anxiety (hazard ratio [HR] 2.79, 95% CI 1.11
to 7.03; p  0.029) (Table 5) explained away the relation-
ship between depressive symptoms and cardiac events. This
stepwise multivariate Cox regression also retained LVEF
50% (HR 2.29, 95% CI 1.01 to 5.21; p  0.047) and age
58 years (HR 2.44, 95% CI 1.01 to 5.88; p  0.047) as
independent predictors of major cardiac events (Table 5,
top). Neither depression (p  0.44) nor hostility (p  0.39)
predicted major cardiac events in this multivariate model.
Regarding increased health care consumption, a stepwise
logistic regression model again retained anxiety (OR 2.00,
95% CI 1.24 to 3.22; p  0.005) as an independent
predictor of frequent visits to the outpatient cardiac clinic or
rehospitalizations due to cardiac events (Table 5, bottom).
Neither depression (p  0.65) nor hostility (p  0.93)
predicted increased health care consumption. In other
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words, anxiety accounted for the relationship between de-
pression and cardiac events, and anxiety was the only
significant predictor of increased health care consumption in
survivors of acute MI.
DISCUSSION
The findings of the present study showed that symptoms of
both depression and anxiety were associated with an in-
creased risk of adverse cardiac events. However, anxiety was
an independent predictor of cardiac events and increased
health care consumption and accounted for the relationship
between depression and prognosis. These findings support
the notion that psychological factors are related to a poor
prognosis after MI (1–3) and indicate that symptoms of
anxiety need to be considered in the risk stratification and
treatment of post-MI patients.
The fact that anxiety was a stronger predictor of cardiac
outcome in MI patients than depressive symptomatology is
a novel finding. A recent review of negative emotions and
the onset of coronary heart disease (CHD) in initially
healthy individuals also concluded that research should not
ignore the risk associated with anxiety (40). The present
study focused on patients with established CHD to examine
the relative impact of symptoms of depression and anxiety
on prognosis. Although most previous research focused on
either anxiety (1–3) or depression (4) as single risk indica-
tors, these negative emotions were investigated simulta-
neously in the present study. Although there was a trend for
depressive symptoms to predict cardiac outcome on univar-
iate analysis, anxiety explained away this association on
multivariate analysis. In fact, anxiety was associated with a
more than twofold increased risk (HR 2.79, 95% CI 1.11 to
Table 1. Baseline Demographic Data, Medications, and Coronary Artery Disease Risk Factors
and Their Univariate Relationship With Depression, Anxiety, and Hostility
Cross Tabulations
Depression Anxiety Hostility
n/N p Value n/N p Value n/N p Value
Age 58 yrs
Yes 64/156 84/155 93/155
No 83/156 0.031 101/156 0.058 100/156 0.456
LVEF 50%
Yes 67/141 84/141 81/140
No 80/171 0.897 101/170 0.977 112/171 0.167
Beta-blockers
Yes 87/185 109/184 121/184
No 60/127 0.969 76/127 0.915 72/127 0.105
PAI
Yes 133/285 164/284 174/284
No 7/15 0.999 13/15 0.026 12/15 0.145
ACE inhibitors
Yes 46/109 58/109 64/108
No 94/190 0.225 119/189 0.099 121/190 0.449
Diuretics
Yes 10/26 12/26 14/25
No 127/269 0.393 163/268 0.146 168/269 0.525
Lipid-lowering drugs
Yes 62/135 79/135 82/135
No 75/160 0.871 96/159 0.746 100/159 0.705
Oral antidiabetics
Yes 10/17 14/17 13/17
No 126/277 0.284 160/276 0.047 168/276 0.199
Invasive intervention
Yes 57/137 82/137 82/137
No 90/175 0.085 103/174 0.907 111/174 0.477
Smoking
Yes 93/170 108/170 115/170
No 54/142 0.003 77/141 0.111 78/141 0.026
Hypercholesterolemia
Yes 33/63 43/63 47/63
No 114/249 0.349 142/248 0.112 146/248 0.022
Hypertension
Yes 43/89 54/89 58/89
No 104/223 0.789 131/222 0.787 135/222 0.474
Diabetes
Yes 15/27 21/27 21/27
No 132/285 0.358 164/284 0.043 172/284 0.078
ACE  angiotensin-converting enzyme; LVEF  left ventricular ejection fraction; PAI  platelet aggegation inhibitors
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7.03; p  0.029) of cardiac death or recurrent MI after
controlling for disease severity (i.e., LVEF50%; HR 2.29,
95% CI 1.01 to 5.21; p 0.047) and age (HR 2.44, 95% CI
1.01 to 5.88; p  0.047). The fact that anxiety, but not
depression, was retained as an independent predictor of
cardiac outcome is in line with the findings of a recent study
by Watkins et al. (28), who found that high levels of anxiety,
measured 6  3 days after MI, but not depression, were
independently associated with reduced vagal control in
post-MI patients. Previous research in our own group also
indicated that anxiety was a significant predictor of clinical
depression in a sample of 206 post-MI patients (39).
Hostility was not associated with cardiac prognosis or
increased health care consumption in the present study.
Our findings confirm studies which concluded that de-
pression and anxiety may be predictors of cardiac events
after MI (20,21). The follow-up period (1 year) in studies
that could not confirm a relationship between depression/
anxiety and cardiac events (17,18) was considerably shorter
than the follow-up period in the present study (average 3.4
years). It may be that cardiac events related to affective
dysregulation after MI tend to occur more in long-term
periods. The timing of the assessment may also be impor-
tant. In a study reporting that both depression and anxiety
did not predict outcome at three years after MI (41), the
depression and anxiety symptoms were assessed in the
hospital. In the present study, these symptoms were assessed
at one month after MI.
Study limitations. The limitations of this study include the
relatively small number of cardiac events, the exclusion of
Table 2. Cardiac Events During Follow-Up as a Function of
Age and Cardiovascular Variables at Baseline
Major Cardiac Events
% n/N HR 95% CI p Value*
Age 58 yrs
Yes 19 (18/94) 2.27 0.95–5.44 0.066
No 9 (7/75)
LVEF 50%
Yes 25 (16/72) 2.46 1.08–5.57 0.031
No 8 (9/97)
Beta-blockers
Yes 16 (15/100) 1.33 0.58–3.0 0.501
No 15 (10/69)
Invasive intervention†
Yes 12 (8/74) 0.57 0.25–1.33 0.197
No 18 (17/95)
Smoking
Yes 11 (10/90) 0.59 0.26–1.30 0.187
No 20 (15/79)
Hypercholesterolemia
Yes 9 (3/35) 0.62 0.19–2.09 0.441
No 17 (22/134)
Hypertension
Yes 21 (9/47) 1.73 0.76–3.92 0.193
No 13 (16/122)
Diabetes
Yes 14 (2/14) 0.94 0.22–4.0 0.933
No 15 (23/155)
*Two-tailed level of significance (univariate Cox regression analyses). †Invasive
intervention: percutaneous transluminal coronary angioplasty or coronary artery
bypass graft surgery.
CI  confidence interval; HR  hazard ratio; LVEF  left ventricular ejection
fraction.
Table 3. Increased Health Care Consumption as a Function of
Age, Cardiovascular Variables, and Emotional Distress at
Baseline
Increased Health Care Consumption
% n/N OR 95% CI p Value
Age 58 yrs
Yes 55 (81/148) 0.74 0.47–1.17 0.200
No 47 (68/144)
LVEF 50%
Yes 57 (72/126) 1.54 0.97–2.46 0.069
No 46 (77/166)
Beta-blockers
Yes 50 (85/169) 1.07 0.67–1.71 0.769
No 52 (64/123)
Invasive intervention†
Yes 50 (64/129) 1.11 0.70–1.76 0.667
No 52 (85/163)
Smoking
Yes 51 (82/162) 0.96 0.61–1.53 0.876
No 52 (67/130)
Hypercholesterolemia
Yes 48 (30/62) 0.87 0.50–1.53 0.640
No 52 (119/230)
Hypertension
Yes 53 (42/79) 1.12 0.67–1.89 0.657
No 50 (107/213)
Diabetes
Yes 52 (13/25) 1.04 0.46–2.37 0.919
No 51 (136/267)
Depression
Yes 58 (77/133) 1.61 1.00–2.57 0.047
No 46 (71/154)
Anxiety
Yes 59 (98/166) 2.02 1.25–3.25 0.004
No 42 (50/120)
Hostility
Yes 54 (96/178) 1.31 0.81–2.11 0.271
No 47 (51/108)
*Two-tailed level of significance (univariate Cox regression analyses). †Invasive
intervention: percutaneous transluminal coronary angioplasty or coronary artery
bypass graft surgery.
OR  odds ratio; other abbreviations as in Table 2.
Figure 1. Cardiac events during follow-up as a function of emotional
distress at baseline. Open bars  low score; solid bars  high score.
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female patients, and the lack of information on depression
treatment during the course of follow-up. However, as yet,
it is not clear whether treatment of post-MI depression can
improve the prognosis (42). Another limitation concerns
the use of only one instrument to assess specific symptoms
of depression and anxiety. Undoubtedly, measures of de-
pressive symptoms may yield significant prognostic infor-
mation in post-MI patients (40)..At the present time, we do
not know what elements of depression predict cardiac mortal-
ity. However, the present findings suggest that, in addition to
assessing depressive symptomatology, it is equally important to
assess other negative emotions, including anxiety.
Apart from a cardiac prognosis, the present study also
examined the prognostic role of emotional distress on health
care consumption. Depression not only precedes cardiac
death and recurrent MI but also may predict morbidity (33).
We found that anxiety was an independent predictor of
frequent visits to the outpatient cardiac clinic or rehospital-
izations due to cardiac events. There was a trend for
symptoms of depression to also be related to increased
health care consumption, but once again, anxiety accounted
for this association in the multivariate model. Hence, it is
also important to detect and treat emotionally distressed
patients from an economic point of view, given the fact that
increased health care consumption entails a significant increase
in health care costs among patients with CHD (34).
These findings have implications for clinical research and
practice. First, biobehavioral research on CHD has largely
focused on depression and depressive symptoms (9–12). It
is timely to also include other psychological factors such as
anxiety (40). Second, the identification of CHD patients
who experience anxiety may lead to more accurate risk
estimates in clinical practice. Compared with the Beck
Depression Inventory, total Hospital Anxiety and Depres-
sion Scale (combination of the anxiety and depression
subscale) proved to be more sensitive and specific to
depression after MI than the subscales separately (39). This
appears to be in line with the results of the present study
(i.e., the fact that symptoms of anxiety were predictive of
cardiac events in addition to symptoms of depression).
Third, as yet, it is not clear whether pharmacologic (36) or
behavioral (42,43) treatment of depression can influence the
prognosis of post-MI patients (7,44). The present study
indicated that besides depression, anxiety is also important
in the prediction of cardiac outcome. This finding may help
to explain why an intervention that was specifically designed
to treat depression (37) failed to improve the prognosis of
post-MI patients (44). A more comprehensive approach to
treatment, including exercise training and individualized
treatment of a wide variety of psychological factors, may be
more successful in improving the cardiac prognosis (8).
Conclusions. We found that anxiety was an independent
predictor of cardiac events and increased health care con-
sumption after controlling for disease severity and age.
Moreover, anxiety accounted for any associations between
depressive symptoms and prognosis. These findings support
the notion that symptoms of emotional distress are related
Table 5. Independent Predictors of Major Cardiac Events and
Health Care Consumption
Cardiac Events*
HR 95% CI p Value†
Anxiety 2.79 1.11–7.03 0.030
Age 58 yrs 2.44 1.01–5.88 0.047
LVEF 50% 2.29 1.01–5.21 0.047
Variables not in the equation
Depression 0.447
Hostility 0.392
Use of antidepressants 0.137
Health Care Consumption‡
OR 95% CI p Value†
Anxiety 2.00 1.24–3.22 0.005
Variables not in the equation
Depression 0.645
Hostility 0.929
Age 58 yrs 0.494
LVEF 50% 0.089
Use of antidepressants 0.937
*Using a Cox regression model. †Two-tailed level of significance. ‡Using a logistic
regression model.
Abbreviations as in Tables 2 and 3.
Table 4. Poor Outcome as a Function of One Negative
Emotion at a Time, Adjusting for Age, Left Ventricular
Ejection Fraction, and Use of Antidepressants
Cardiac Events*
HR 95% CI p Value†
Depression 2.32 1.04–5.18 0.039
Age 58 yrs 2.06 0.86–4.96 0.107
LVEF 50% 2.14 0.94–4.87 0.070
Use of antidepressants 0.979
Anxiety 3.01 1.20–7.60 0.019
Age 58 years 2.22 0.93–5.36 0.073
LVEF 50% 2.09 0.92–4.75 0.078
Use of antidepressants 0.979
Hostility 1.03 0.46–2.30 0.950
Age 58 yrs 1.94 0.80–4.70 0.142
LVEF 50% 2.18 0.96–4.97 0.064
Use of antidepressants 0.978
Health Care Consumption‡
OR 95% CI p Value
Depression 1.55 0.96–2.52 0.076
Age 58 yrs 0.79 0.49–1.28 0.339
LVEF 50% 1.57 0.97–2.53 0.065
Use of antidepressants 1.00 0.42–2.35 0.994
Anxiety 2.00 1.23–3.26 0.006
Age 58 yrs 0.81 0.50–1.31 0.395
LVEF 50% 1.57 0.97–2.55 0.067
Use of antidepressants 1.07 0.46–2.51 0.881
Hostility 1.33 0.81–2.16 0.257
Age 58 yrs 0.75 0.47–1.24 0.245
LVEF 50% 1.60 0.99–2.58 0.055
Use of antidepressants 0.90 0.39–2.09 0.804
*Using a Cox regression model. †Two-tailed level of significance. ‡Using a logistic
regression model.
Abbreviations as in Tables 2 and 3.
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to the cardiac prognosis after MI. Yet, they also indicate
that, apart from depressive symptoms, other symptoms of
emotional distress must be considered to optimize risk
stratification and treatment.
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